Stock Movers Juventus's Crypto Bid, Sanofi Setbacks, TT Electronics Falls
Dec 15, 2025
Louise Moon, a Bloomberg breaking news editor, dives into the latest market movements. She discusses how Juventus's shares skyrocketed after Exor NV rejected Tether Holdings' unwanted acquisition bid. Moon also highlights Sanofi's double setback with a US regulatory delay and a failed clinical trial for its MS drug. Lastly, she covers the 22% plunge of TT Electronics after DBAY Advisors decided against a takeover bid. Tune in for a sharp analysis of these pressing financial topics!
AI Snips
Chapters
Transcript
Episode notes
Exor Rejects Crypto Buyout Bid
- Exor rejected Tether's unsolicited bid and says it won't sell its Juventus stake.
- Juventus shares rose the most this year after the rejection, reflecting investor relief.
Sanofi Hit By Regulatory And Trial Setbacks
- Sanofi faced a regulatory delay in the US and a late-stage trial failure for its MS drug.
- The setbacks threaten peak sales and revive concerns about prior liver-injury signals.
Takeover Hopes Fade For TT Electronics
- D-Bay Advisors said it will not make a takeover offer for TT Electronics after previously signalling a rival bid.
- TT shares plunged as investors reassessed the takeover outlook and vote dynamics.